Both in Biotechnology
Krystal Biotech vs Repligen
Over the past year KRYS returned +68.0% and RGEN returned +17.8%; their daily moves had a correlation of 0.26.
KRYS +68.0% RGEN +17.8%Growth of $1, one year, split-adjusted
| Metric | KRYS | RGEN |
|---|---|---|
| Price | $332.29 | $176.94 |
| Market cap | $9.84B | $11.23B |
| Today | +2.38% | −6.20% |
| 1 month | +2.1% | −0.2% |
| 6 months | +24.9% | +51.0% |
| Year to date | +34.8% | +8.0% |
| 1 year | +79.6% | +19.2% |
| Revenue growth (YoY) | +24.1% | +10.9% |
| Gross margin | 94.6% | 53.0% |
| Net margin | 45.9% | −18.4% |
| P/E (TTM) | 40.7× | — |
| Price / sales | 22.3× | 13.9× |
| Net cash | $845.6M | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 30.6% | 47.0% |
| Short % of float | 12.9% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).